Comparable stake leader
Jeffrey B. Shealy
SEC ownership of Palomino Laboratories Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001938569.
Disclosed value leader
Exor N.V.
Comparable rows
4/11
Latest evidence
31 Jul 2026
- Public ticker
- PALX on OTC
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jeffrey B. Shealy
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
4 of 11
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Jeffrey B. Shealy
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001938569
- Issuer location
- Goleta, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Palomino Laboratories Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jeffrey B. Shealy
Disclosed value leader
Exor N.V.
Comparable rows
4/11
Latest evidence
31 Jul 2026
3/4/5
13D/G
13F
Lead comparable stake: 24%
7 rows are not safely comparable across share classes.
13D/G row: Jeffrey B. Shealy
Showing 1-8 of 11 holder rows.
Quick read
Jeffrey B. Shealy leads the comparable SEC ownership view at 24%.
4 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jeffrey B. Shealy's linked filing trail.
Comparable ownership
Top 4
Jeffrey B. Shealy
24%
Lucius Partners LLC
23%
Steven DenBaars
9.4%
Richard Ogawa
6.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jeffrey B. Shealy |
3/4/5
13D/G
President and CEO, Director, 10%+ Owner · Shealy Jeffrey B.
|
24%
Reported 13D/G
· 29 Sep 2025
|
$28,279,996
9,333,332 shares
mixed-class rows
|
— | 29 Sep 2025 |
| Lucius Partners LLC |
3/4/5
13D/G
10%+ Owner
|
23%
Reported 13D/G
· 29 Sep 2025
|
—
4,000,000 shares
|
— | 29 Sep 2025 |
| Steven DenBaars |
3/4/5
13D/G
Director
|
9.4%
Reported 13D/G
· 29 Sep 2025
|
$8,715,750
1,887,500 shares
mixed-class rows
|
— | 20 Apr 2026 |
| Richard Ogawa |
13D/G
3/4/5
Secretary, Director
|
6.9%
Reported 13D/G
· 31 Jul 2026
|
$23,060,625
1,882,500 shares
|
+$1,623,125 | 31 Jul 2026 |
| Exor N.V. |
13F
Company
|
—
denominator unverified
|
$5,055,509,678
185,932,684 shares
|
— | 30 Jun 2026 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$30,275,391
5,680,186 shares
|
— | 30 Jun 2026 |
| GAGNON SECURITIES LLC |
13F
Company
|
—
denominator unverified
|
$11,697,619
765,179 shares
|
— | 30 Jun 2026 |
| Gagnon Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$6,119,731
328,488 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 21 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-6 of 6 reporting-owner rows connected to Palomino Laboratories Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
6
Largest Forms 3/4/5 holder
Jeffrey B. Shealy
Net 12M change
$0
Latest report
31 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jeffrey B. Shealy | President and CEO, Director, 10%+ Owner | $28,279,996 | Mixed | 29 Sep 2025 | ||
| Steven DenBaars | Director | $8,715,750 | Mixed | 20 Apr 2026 | ||
| Richard Ogawa | Secretary, Director | $8,715,750 | Mixed | 31 Jul 2026 | ||
| Jason Tu | Chief Accounting Officer | $657,505 | Mixed | 29 Sep 2025 | ||
| Lucius Partners LLC | 10%+ Owner | Mixed | 29 Sep 2025 | |||
| Nathan P. Pereira | President, CEO, CFO, Director | Mixed | 09 Oct 2023 |
Recent insider transactions for Palomino Laboratories Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Richard Ogawa | PALX | Common Stock | Other | 6.81% | 120,000 | 1,882,500 | 31 Jul 2026 | Direct | ||
| Richard Ogawa | Common Stock | Purchase | 0.71% | 12,500 | 1,762,500 | 20 Apr 2026 | Direct | |||
| Steven Denbaars | Common Stock | Purchase | 0.71% | 12,500 | 1,762,500 | 20 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.